Neuroimaging in Neuro-Oncology

Neurologic Clinics

Volumn 27, Issue 1, 2009, Pages 171-201

  Mechtler, Laszlo ^a  

^a DENT NEUROLOGIC INSTITUTE   (United States)

Author keywords

Brain tumors; MRI; Neuro oncology; Neuroimaging

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; GADOLINIUM;

ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CEREBROSPINAL FLUID FLOW; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; EPENDYMOMA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GIANT CELL TUMOR; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE ANGIOGRAPHY; MEDULLOBLASTOMA; MENINGIOMA; MOLECULAR IMAGING; MULTIPLE MYELOMA; NEURILEMOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PERFUSION WEIGHTED IMAGING; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY; SPIN LABELING; TREATMENT RESPONSE; WHITE MATTER;

BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; HUMANS;

EID: 56849087906     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.09.015     Document Type: Review

References (113)

1. CBTRUS. Statistical report: primary brain tumors in the United States 2000-2004. Central brain tumor registry of the United States data 2000-2004. Available at: www.cbtrus.org/reports/reports.html.
2. Jemal A., Siegal R., Word E., et al. Cancer statistics 2007. CA Cancer J Clin. 57 1 (2007) 43-66
3. Buckner J.C., Brown P.D., O'Neill B.P., et al. Central nervous system tumors. Mayo Clin Proc 82 10 (2007) 1271-1286
4. Terae S., Yoshida D., Kudo K., et al. Contrast-enhanced FLAIR imaging in combination with pre- and postcontrast magnetization transfer T1-weighted imaging: usefulness in the evaluation of brain metastases. J Magn Reson Imaging 25 (2007) 479-487
5. Thomas B., Krishnamoorthy T., Kapilamoorthy T., et al. Contrast enhanced FLAIR imaging in ibuprofen induced aseptic meningitis. Eur J Radiol Extra 60 3 (2006) 97-99
6. Husstedt H.W., Sickert M., Kostler H., et al. Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors. Eur Radiol 10 5 (2000) 745-752
7. Essig M., Hawighorst H., Schoenberg S.O., et al. Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors. J Magn Reson Imaging 8 4 (1988) 789-798
8. Delfaut E.M., Beltran J., Johnson G., et al. Fat suppression in MR imaging: techniques and pitfalls. Radiographics 19 2 (1999) 373-382
9. Bauer-Melnyk A., Buhmann S., Becker C., et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 190 4 (2008) 1097-1104
10. Chan M.S., Roebuck D.J., Yuen M.P., et al. MR imaging of the brain in patients cured of acute lymphoblastic leukemia-the value of gradient echo imaging. AJNR Am J Neuroradiol 27 3 (2006) 548-552
11. Patel M.R., Siewert B., Klufas R., et al. Echoplanar MR imaging for ultra-fast detection of brain lesions. AJR Am J Roentgenol 173 (1999) 479-485
12. Knauth M., Forsting M., Hartmann M., et al. MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. AJNR Am J Neuroradiol 17 (1996) 1853-1859
13. Finelli D.A., Hurst G.C., Gullapali R.P., et al. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer. Radiology 190 2 (1994) 553-559
14. Lee J.M., Jung S., Moon K.S., et al. Preoperative evaluation of venous systems with 3-dimensional contrast-enhanced magnetic resonance venography in brain tumors: comparison with time-of-flight MRV and digital subtraction angiography. Surg Neurol 64 2 (2005) 128-133
15. Atlas S.W., Lavi E., and Fisher P.G. Intra-axial brain tumors. In: Atlas S.W. (Ed). Magnetic resonance imaging of the brain and spine. 3rd edition (2002), Lippincott Williams Wilkins, Philadelphia
16. Forsyth P.A., Petrov E., Mahallati H., et al. Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 15 5 (1997) 2076-2081
17. Vidiri A., Carapella C.M., Pace A., et al. Early post-operative MRI: correlation with progression-free survival and overall survival time in malignant gliomas. J Exp Clin Cancer Res 25 2 (2006) 177-182
18. Joffe P., Thomsen H.S., and Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5 (1998) 491-502
19. Wiginton C.D., Kelly B., Oto A., et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 190 4 (2008) 1060-1068
20. Cowper S.E. Nephrogenic systemic fibrosis: an overview. J Am Coll Radiol 5 1 (2008) 23-28
21. Louis D.N., Ohgaki H., Wiestler O.D., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 2 (2007) 97-109
22. Koeller K.K., and Rushing E.J. From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 24 6 (2004) 1693-1708
23. Beni-Adani L., Gomori M., Spektor S., et al. Cyst wall enhancement in pilocytic astrocytoma: neoplastic or reactive phenomenon. Pediatr Neurosurg 32 (2000) 234-239
24. Arai K., Sato N., Aoki J., et al. MR signal of the solid portion of pilocytic astrocytoma on T2-weighted images: is it useful for differentiation from medulloblastoma?. Neuroradiology 48 4 (2006) 233-237
25. Lipper M.H., Eberhard D.A., Phillips C.D., et al. Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor: neuroradiologic and pathologic features. AJNR: Am J Neuroradiol 14 (1993) 1397-1404
26. Crespo-Rodriguez A.M., Smirniotopoulos J.G., and Rushing E.J. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology 49 4 (2007) 307-315
27. Luat A.F., Makki M., and Chugani H.T. Neuroimaging in tuberous sclerosis complex. Curr Opin Neurol 20 2 (2007) 142-150
28. Nishio S., Morioka T., Suzuki S., et al. Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases. J Clin Neurosci 8 1 (2001) 31-34
29. Wessels P.H., Weber W.E., Raven G., et al. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2 7 (2003) 395-403
30. Recht L.D., and Bernstein M. Low-grade gliomas. Neurol Clin 13 (1995) 847-859
31. Barker II F.G., Chang S.M., Huhn S.L., et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80 5 (1997) 936-941
32. See S.J., and Gilbert M.R. Anaplastic astrocytoma: diagnosis, prognosis, and management. Semin Oncol 31 5 (2004) 618-634
33. Tortosa A., Vinolas N., Villa S., et al. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 97 4 (2003) 1063-1071
34. Peretti-Viton P., Brunel H., Chinot O., et al. Histological and MR correlations in gliomatosis cerebri. J Neurooncol 59 3 (2002) 249-259
35. Vates G.E., Chang S., Lamborn K.R., et al. Gliomatosis cerebri: a review of 22 cases. Neurosurgery 53 2 (2003) 261-271
36. Osborn A.G. Diagnostic imaging: brain. 1st edition. (2004), Amirsys, Salt Lake City
37. Pierallini A., Bonamini M., Pantano P., et al. Radiological assessment of necrosis in glioblastoma: variability and prognostic value. Neuroradiology 40 3 (1998) 150-153
38. Lafitte F., Morel-Precetti S., Martin-Duverneuil N., et al. Multiple glioblastomas: CT and MR features. Eur Radiol 11 1 (2001) 131-136
39. Heimberger A.B., Hlatky R., Suki D., et al. Prognostic effect of epidermal growth factor receptor and EGFR vIII in glioblastoma multiforme patients. Clin Cancer Res 11 (2005) 1462-1466
40. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95 2 (2001) 190-198
41. White M.L., Zhang Y., Kirby P., et al. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?. AJNR: Am J Neuroradiol 26 4 (2005) 784-790
42. Jenkinson M.D., du Plessis D.G., Smith T.S., et al. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 129 (2006) 1884-1891
43. Megyesi J.F., Kachur E., Lee D.H., et al. Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10 13 (2004) 4303-4306
44. Daumas-Duport C., Varlet P., Tucker M.L., et al. Oligodendrogliomas. Part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34 (1997) 37-59
45. Reiche W., Grunwald I., Hermann K., et al. Oligodendrogliomas. Acta Radiol 43 5 (2002) 474-482
46. Mermuys K., Jeuris W., Vanhoenacker P.K., et al. Best cases from the AFIP: supratentorial ependymoma. Radiographics 25 2 (2005) 486-490
47. Comi A.M., Backstrom J.W., Burger P.C., et al. Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric Oncology Group. Pediatr Neurol 18 1 (1998) 23-29
48. Bühring U., Herrlinger U., Krings T., et al. MRI features of primary central nervous system lymphomas (PCNSL) at presentation. Neurology 57 (2001) 393-396
49. Kuker W., Nagele T., Korfel A., et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72 (2005) 169-177
50. Mohile N.A., and Abrey L.E. Primary central nervous system lymphoma. Neurol Clin 25 4 (2007) 1193-1207
51. Slone H.W., Blake J.J., Shah R., et al. CT and MRI findings of intracranial lymphoma. AJR: Am J Roentgenol 184 5 (2005) 1679-1685
52. Bendszus M., Warmuth-Metz M., Klein R., et al. Sequential MRI and MR spectroscopy in embolized meningiomas: correlation with surgical and histopathological findings. Neuroradiology 44 1 (2002) 77-82
53. Tamiya T., Ono Y., Matsumoto K., et al. Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors. Neurosurgery 49 5 (2001) 1046-1051 [discussion 1051-2]
54. Maiuri F., Iaconetta G., de Divitiis O., et al. Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 31 1 (1999) 69-75
55. Chenevert T.L., Sundgren P.C., and Ross B.D. Diffusion imaging: insight to cell status and cytoarchitecture. Neuroimaging Clin N Am 16 4 (2006) 619-632
56. Chen S., Ikawa F., Kurisu K., et al. Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging. AJNR: Am J Neuroradiol 22 6 (2001) 1089-1096
57. Hartmann M., Jansen O., Heiland S., et al. Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. AJNR: Am J Neuroradiol 22 9 (2001) 1738-1742
58. Kono K., Inoue Y., Nakayama K., et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR: Am J Neuroradiol 22 (2001) 1081-1088
59. Filippi C.G., Edgar M.A., Ulug A.M., et al. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR: Am J Neuroradiol 22 (2001) 65-72
60. Murakami R., Sugahara T., Nakamura H., et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 243 (2007) 493-499
61. Lu S., Ahn D., Johnson G., et al. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR 24 (2003) 937-941
62. Yamasaki F., Kurisu K., Satoh K., et al. Apparent diffusion coefficient of human brain tumors of MR imaging. Radiology 235 (2005) 985-991
63. Provenzale J.M., McGraw P., Mhatre P., et al. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 232 2 (2004) 451-460
64. Smith J.S., Cha S., Mayo M.C., et al. Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 103 (2005) 428-438
65. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR: Am J Neuroradiol 27 (2006) 475-487
66. Asao C., Korogi Y., Kitajima M., et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR: Am J Neuroradiol 26 (2005) 1455-1460
67. Yu C.S., Li K.C., Xuan Y., et al. Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment. Eur J Radiol 56 (2005) 197-204
68. Jena R., Price S.J., Baker C., et al. Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma. Clin Oncol 17 (2005) 581-590
69. Toh C.H., Wong A.M.C., Wei K.C., et al. Peritumoral edema of meningiomas and metastatic brain tumors: differences in diffusion characteristics evaluated with diffusion-tensor MR imaging. Neuroradiology 49 (2007) 489-494
70. Price S.J., Jena R., Burnet N.G., et al. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. AJNR: Am J Neuroradiol 27 (2006) 1969-1974
71. Price S.J., Pena A., Burnet N.G., et al. Detecting glioma invasion of the corpus callosum using diffusion tensor imaging. Br J Neurosurg 18 (2004) 391-395
72. Cha S. CNS tumors: monitoring therapeutic response and outcome prediction. Top Magn Reson Imaging 17 (2006) 63-68
73. Fan G.G., Deng Q.L., Wu Z.H., et al. Usefulness of diffusion/perfusion-weighted MRI in patients with nonenhancing supratentorial brain gliomas: a valuable tool to predict tumour grading. Br J Radiol 79 (2006) 652-658
74. Cha S., Tihan T., Crawford F., et al. Differentiation of low grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR: Am J Neuroradiol 26 (2005) 266-273
75. Law M., Oh S., Babb J.S., et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging: prediction of patient clinical response. Radiology 238 (2006) 658-667
76. Weber M.A., Zoubaa S., Schlieter M., et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66 (2006) 1899-1906
77. Law M., Cha S., Knopp E.A., et al. High grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222 (2002) 715-721
78. Maia Jr. A.C., Malheiros S.M., da Rocha A.J., et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR: Am J Neuroradiol 26 (2005) 777-783
79. Warmuth C., Günther M., and Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 228 (2003) 523-532
80. Essig M., Weber M.A., Von Tengg-Kobligk H., et al. Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications. Top Magn Reson Imaging 17 (2006) 89-106
81. Astrakas L.G., Zurakowski D., Tzika A.A., et al. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10 (2004) 8220-8228
82. Fountas K.N., Kapsalaki E.Z., Vogel R.L., et al. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 82 (2004) 90-97
83. Stadlbauer A., Gruber S., Nimski C., et al. Preoperative grading of gliomas using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238 (2006) 958-969
84. Tzika A.A., Zarifi M.K., Goumnerova L., et al. Neuroimaging in pediatric brain tumors: GD-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. AJNR: Am J Neuroradiol 23 (2002) 322-333
85. Hollingworth W., Medina L.S., Lenkinski R.E., et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR: Am J Neuroradiol 27 (2006) 1404-1411
86. Sibtain N.A., Howe F.A., and Saunders D.E. The clinical value of proton magnetic resonance spectroscopy in adult brain tumors. Clin Radiol 62 (2007) 109-119
87. Henson J.W., Ulmer S., and Harris G.J. Brain tumor imaging in clinical trials. AJNR: Am J Neuroradiol 29 3 (2008) 419-424
88. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
89. Macdonald D.R., Cascino T.L., Schold S.C., et al. Response criteria for phase II studies of malignant glioma. J Clin Oncol 8 (1990) 1277-1280
90. Galanis E., Buckner J.C., Maurer M.J., et al. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 8 (2006) 156-165
91. Ulmer S., Braga T.A., Barker F.G., et al. Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology 67 (2006) 1668-1670
92. Pope W.B., Lai A., Nghiemphu P., et al. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology 66 (2006) 1258-1260
93. Bogomolny D.L., Petrovich N.M., Hou B.L., et al. Functional MRI in the brain tumor patient. Top Magn Reson Imaging 15 5 (2004) 325-335
94. Medina L.S., Aguirre E., Bernal B., et al. Functional MRI imaging versus WADA test for evaluation of language lateralization: cost analysis. Radiology 230 (2004) 49-54
95. Haberg A., Kvistad K.A., Unsgard G., et al. Preoperative blood oxygen level-dependent functional magnetic resonance imaging in patients with primary brain tumors: clinical application and outcome. Neurosurgery 54 (2004) 902-914
96. Sunaert S. Presurgical planning for tumor resectioning. J Magn Reson Imaging 23 6 (2006) 887-905
97. Petrella J.R., Shah L.M., Harris K.M., et al. Preoperative functional MR imaging localization of language and motor areas: effect on therapeutic decision making in patients with potentially resectable brain tumors. Radiology 240 (2006) 793-802
98. Yuh W.T., Christoforidis G.A., Koch R.M., et al. Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-of-the-art review. Top Magn Reson Imaging 17 (2006) 53-61
99. Lupo J.M., Lee M.C., Han E.T., et al. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3 T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction. J Magn Reson Imaging 24 (2006) 520-529
100. Roberts T.P., and Mikulis D. Neuro MR: principles. J Magn Reson Imaging 26 4 (2007) 823-837
101. Krautmacher C., Willinek W.A., Tschampa H.J., et al. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T: initial experience. Radiology 237 (2005) 1014-1019
102. Sehgal V., Delproposto Z., Haddar D., et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24 1 (2006) 41-51
103. Jolesz F.A., Talos I.F., Warfield S.K., et al. Magnetic resonance image-guided neurosurgery. In: Newton H.B., and Jolesz F.A. (Eds). Handbook of neuro-oncology neuroimaging. 1st edition (2008), Elsevier, New York 171-180
104. Chu R.M., Tummala R.P., and Hall W.A. Intraoperative magnetic resonance image-guided neurosurgery. Neurosurg Q 13 (2003) 234-250
105. Hall W.A., and Truwit C.L. Intraoperative MR-guided neurosurgery. J Magn Reson Imaging 27 2 (2008) 368-375
106. Busse H., Schmitgen A., Trantakis C., et al. Advanced approach for intraoperative MRI guidance and potential benefit for neurosurgical applications. J Magn Reson Imaging 24 1 (2006) 140-151
107. Hall W.A., Galicich W., Bergman T., et al. 3-Tesla intraoperative MRI imaging for neurosurgery. J Neurooncol 77 (2006) 297-303
108. Kinoshita M., McDannold N., Jolesz F.A., et al. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 340 4 (2006) 1085-1090
109. Hynynen K., McDannold N., Sheikov N.A., et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24 1 (2005) 12-20
110. Anderson S.A., Glod J., Arbab A.S., et al. Non-invasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105 (2005) 420-425
111. Hsu A.R., and Chen X. Advances in anatomic, functional, and molecular imaging of angiogenesis. J Nucl Med 49 (2008) 511-514
112. Shah K., Jacobs A., Breakefield X.O., et al. Molecular imaging of gene therapy for cancer. Gene Ther 11 (2004) 1175-1187
113. Jackson A., O'Connor J.P.B., Parker G.J.M., et al. Imaging tumor vascular heterogeneity and angiogenesis using DCE-MRI. CCR focus. Clin Cancer Res 13 (2007) 3449-3459